FIELD: biotechnology.
SUBSTANCE: invention relates to a novel crystalline form III of N-(1-t-butylbutyl)-N'-(2-ethyl-3-methoxybenzoyl)-hydrazide(R)-3,5-dimethylbenzoic acid. The present invention also provides compositions comprising a crystalline Form III, a method for its obtaining and usage in order to regulate gene expression in cell or in subject.
EFFECT: improved properties of compounds.
20 cl, 32 dwg, 12 tbl, 17 ex
Authors
Dates
2017-08-24—Published
2012-09-07—Filed